Cronos Group Inc
TSX:CRON

Watchlist Manager
Cronos Group Inc Logo
Cronos Group Inc
TSX:CRON
Watchlist
Price: 4.49 CAD 14.83% Market Closed
Market Cap: 1.7B CAD

EV/EBITDA
Enterprise Value to EBITDA

-64.4
Current
0.8
Median
13
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-64.4
=
Enterprise Value
584.5m CAD
/
EBITDA
-6.6m USD
All Countries
Close
EBITDA Growth EV/EBITDA to Growth
CA
Cronos Group Inc
TSX:CRON
Average EV/EBITDA: 438.7
Negative Multiple: -64.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
35.5
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.6
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.5
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108
10%
10.8
CH
Novartis AG
SIX:NOVN
11.2
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.3
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.6
2%
4.8
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
1%
7.6

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
25.2
2-Years Forward
EV/EBITDA
37.4
3-Years Forward
EV/EBITDA
82.1